Phosphodiesterase inhibitors for pulmonary hypertension.
作者信息
Galiè Nazzareno, Rubin Lewis J, Simonneau Gerald
出版信息
N Engl J Med. 2010 Feb 11;362(6):559-60; author reply 560.
PMID:20175298
Abstract
摘要
相似文献
1
Phosphodiesterase inhibitors for pulmonary hypertension.用于治疗肺动脉高压的磷酸二酯酶抑制剂
N Engl J Med. 2010 Feb 11;362(6):559-60; author reply 560.
2
Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension.用于治疗肺动脉高压的5型磷酸二酯酶抑制剂。
N Engl J Med. 2009 Nov 5;361(19):1864-71. doi: 10.1056/NEJMct0904473.
3
Phosphodiesterase inhibitors for pulmonary hypertension.用于治疗肺动脉高压的磷酸二酯酶抑制剂
N Engl J Med. 2010 Feb 11;362(6):559; author reply 560. doi: 10.1056/NEJMc0912127.
4
Preoperative administration of PDE-5 Inhibitors.磷酸二酯酶-5抑制剂的术前给药。
J Clin Anesth. 2009 Mar;21(2):149; author reply 149-50. doi: 10.1016/j.jclinane.2009.01.001.
5
[Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors].[肺动脉高压的治疗：磷酸二酯酶-5抑制剂]
Dtsch Med Wochenschr. 2006 Dec 8;131(49 Suppl 9):S311-4. doi: 10.1055/s-2006-957199.
6
Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.磷酸二酯酶 5 抑制剂在肺动脉高压中的应用。
Adv Ther. 2009 Sep;26(9):813-25. doi: 10.1007/s12325-009-0064-z. Epub 2009 Sep 19.
7
Phosphodiesterase type 5 inhibition: a support of the left ventricular assist device bridge to transplant.5型磷酸二酯酶抑制：对左心室辅助装置过渡到移植的支持
Circ Heart Fail. 2008 Nov;1(4):211-2. doi: 10.1161/CIRCHEARTFAILURE.108.830570.
8
Phosphodiesterase type 5 inhibitors in pulmonary hypertension: a Hobson's choice for Indian patients.
Indian Heart J. 2007 Jul-Aug;59(4):299-301.
9
Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension.与用于治疗勃起功能障碍或肺动脉高压的磷酸二酯酶-5抑制剂的药物相互作用。
Circulation. 2010 Jul 6;122(1):88-95. doi: 10.1161/CIRCULATIONAHA.110.944603.
10
Sustained benefit of tadalafil in patients with pulmonary arterial hypertension with prior response to sildenafil: a case series of 12 patients.
Int J Cardiol. 2008 Apr 25;125(3):416-7. doi: 10.1016/j.ijcard.2007.01.046. Epub 2007 Apr 3.
引用本文的文献
1
Anti-platelet therapy: phosphodiesterase inhibitors.抗血小板治疗：磷酸二酯酶抑制剂。
Br J Clin Pharmacol. 2011 Oct;72(4):634-46. doi: 10.1111/j.1365-2125.2011.04034.x.
2
Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications.靶向心脏中的环核苷酸磷酸二酯酶：治疗意义。
J Cardiovasc Transl Res. 2010 Oct;3(5):507-15. doi: 10.1007/s12265-010-9203-9. Epub 2010 Jul 15.
Zotero 插件